Parent-of-origin tumourigenesis is mediated by an essential imprinted modifier in SDHD-linked paragangliomas: SLC22A18 and CDKN1C are candidate tumour modifiers.

PubWeight™: 0.78^‹?›

🔗 View Article (PMID 27402879)

Published in Hum Mol Genet on July 08, 2016

Authors

Attje S Hoekstra¹, Ruben D Addie²^,3, Cor Ras⁴, Reza M Seifar⁴, Claudia A Ruivenkamp⁵, Inge H Briaire-de Bruijn³, Frederik J Hes⁵, Jeroen C Jansen⁶, Eleonora P M Corssmit⁷, Willem E Corver³, Hans Morreau³, Judith V M G Bovée³, Jean-Pierre Bayley¹, Peter Devilee⁸^,3

Author Affiliations

1: Department of Human Genetics.
2: Center for Proteomics and Metabolomics.
3: Department of Pathology.
4: Department of Biotechnology, Delft University of Technology, Delft, The Netherlands.
5: Department of Clinical Genetics.
6: Department of Otorhinolaryngology.
7: Department of Endocrinology and Metabolic Diseases, Leiden University Medical Center, Leiden, The Netherlands.
8: Department of Human Genetics p.devilee@lumc.nl.

Articles citing this ↘

Loss of maternal chromosome 11 is a signature event in SDHAF2, SDHD, and VHL-related paragangliomas, but less significant in SDHB-related paragangliomas. Oncotarget (2017) 0.75

SDHB-related pheochromocytoma and paraganglioma penetrance and genotype-phenotype correlations. J Cancer Res Clin Oncol (2017) 0.75

Articles by these authors ⇆

Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma/pheochromocytoma and smooth muscle tumors. Oncotarget (2015) 0.93

Sleep-mediated heart rate variability after bilateral carotid body tumor resection. Sleep (2015) 0.78

No evidence for increased mortality in SDHD variant carriers compared with the general population. Eur J Hum Genet (2015) 0.75

Loss of maternal chromosome 11 is a signature event in SDHAF2, SDHD, and VHL-related paragangliomas, but less significant in SDHB-related paragangliomas. Oncotarget (2017) 0.75

The phenotype of SDHB germline mutation carriers: a nationwide study. Eur J Endocrinol (2017) 0.75